Azienda Ospedaliero Universitaria di Modena_Policlinico - Oncologia

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer	Hot Flashes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Active, not recruiting	Phase 3	2026-07-09	NCT05587296
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies	Biochemically Recurrent Prostate Cancer	Active, not recruiting	Phase 3	2026-07-07	NCT05794906
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)	Metastatic Castrate Resistant Prostate Cancer (mCRPC)	Active, not recruiting	Phase 4	2026-07-06	NCT04597125

Clinical trials